Eli Lilly's Zepbound and Mounjaro now available in U.S. after shortages, FDA says

All doses of a weight loss injection and diabetes drug from Eli Lilly are now available in the U.S., as reported by the Food and Drug Administration’s drug shortage database. The update comes following statements from Eli Lilly’s CEO regarding the end of shortages for the drugs. Both weight loss and diabetes drugs have been in high demand, leading Eli Lilly and its competitor Novo Nordisk to invest heavily in manufacturing.